Gene Therapy is a high risk high reward

back in Oct 2020 -> "an early Moderna ( MRNA ) investor and Harvard PhD, Timothy Springer, continued to pour his fortune into this small cap stock. Mr. Springer also happens to be a director at Selecta Biosciences . He reportedly purchased more than 6,500,000 shares in October. He went on a shopping spree on October 7 when he bought 654,953 shares at $1.65 and continued buying all the way to October 23 when he bought 994,448 shares for $2.71."
Comment: daily chart for the initial entry


Home Stock Screener Forex Screener Crypto Screener Economic Calendar About Chart Features Pricing Refer a friend House Rules Help Center Website & Broker Solutions Widgets Charting Solutions Lightweight Charting Library Blog & News Twitter
Profile Profile Settings Account and Billing Referred friends Coins My Support Tickets Help Center Private Messages Chat Sign Out